APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,904,000 | +203.1% | 101,085 | +100.6% | 0.04% | +169.2% |
| Q2 2022 | $2,278,000 | +132.2% | 50,380 | +161.1% | 0.01% | +225.0% |
| Q1 2022 | $981,000 | +190.2% | 19,298 | +261.1% | 0.00% | +300.0% |
| Q2 2021 | $338,000 | -57.6% | 5,344 | -79.8% | 0.00% | -90.9% |
| Q3 2020 | $797,000 | +7.1% | 26,422 | +15.9% | 0.01% | -8.3% |
| Q2 2020 | $744,000 | +177.6% | 22,790 | +128.1% | 0.01% | +71.4% |
| Q1 2020 | $268,000 | -57.0% | 9,991 | -50.9% | 0.01% | +75.0% |
| Q4 2019 | $623,000 | -41.1% | 20,359 | -53.6% | 0.00% | -55.6% |
| Q3 2019 | $1,057,000 | -34.8% | 43,897 | -31.4% | 0.01% | -43.8% |
| Q2 2019 | $1,622,000 | +80.4% | 64,000 | +38.8% | 0.02% | +60.0% |
| Q1 2019 | $899,000 | +58.8% | 46,111 | +7.5% | 0.01% | +42.9% |
| Q4 2018 | $566,000 | +50.9% | 42,904 | +103.3% | 0.01% | +75.0% |
| Q3 2018 | $375,000 | – | 21,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |